BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

292 related articles for article (PubMed ID: 28281925)

  • 21. Recombinant Mammalian Prions: The "Correctly" Misfolded Prion Protein Conformers.
    Ma J; Zhang J; Yan R
    Viruses; 2022 Aug; 14(9):. PubMed ID: 36146746
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Generation of genuine prion infectivity by serial PMCA.
    Weber P; Giese A; Piening N; Mitteregger G; Thomzig A; Beekes M; Kretzschmar HA
    Vet Microbiol; 2007 Aug; 123(4):346-57. PubMed ID: 17493773
    [TBL] [Abstract][Full Text] [Related]  

  • 23. In situ formation of protease-resistant prion protein in transmissible spongiform encephalopathy-infected brain slices.
    Bessen RA; Raymond GJ; Caughey B
    J Biol Chem; 1997 Jun; 272(24):15227-31. PubMed ID: 9182546
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Pathogenic mechanisms of prion protein, amyloid-β and α-synuclein misfolding: the prion concept and neurotoxicity of protein oligomers.
    Ugalde CL; Finkelstein DI; Lawson VA; Hill AF
    J Neurochem; 2016 Oct; 139(2):162-180. PubMed ID: 27529376
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Abnormal prion protein, infectivity and neurofilament light-chain in blood of macaques with experimental variant Creutzfeldt-Jakob disease.
    Yakovleva O; Bett C; Pilant T; Asher DM; Gregori L
    J Gen Virol; 2022 Jul; 103(7):. PubMed ID: 35816369
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Host and transmissible spongiform encephalopathy agent strain control glycosylation of PrP.
    Somerville RA
    J Gen Virol; 1999 Jul; 80 ( Pt 7)():1865-1872. PubMed ID: 10423157
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Extracellular vesicles with diagnostic and therapeutic potential for prion diseases.
    Khadka A; Spiers JG; Cheng L; Hill AF
    Cell Tissue Res; 2023 Apr; 392(1):247-267. PubMed ID: 35394216
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Familial human prion diseases associated with prion protein mutations Y226X and G131V are transmissible to transgenic mice expressing human prion protein.
    Race B; Williams K; Hughson AG; Jansen C; Parchi P; Rozemuller AJM; Chesebro B
    Acta Neuropathol Commun; 2018 Feb; 6(1):13. PubMed ID: 29458424
    [TBL] [Abstract][Full Text] [Related]  

  • 29. PrP knock-out and PrP transgenic mice in prion research.
    Weissmann C; Flechsig E
    Br Med Bull; 2003; 66():43-60. PubMed ID: 14522848
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Ex vivo mammalian prions are formed of paired double helical prion protein fibrils.
    Terry C; Wenborn A; Gros N; Sells J; Joiner S; Hosszu LL; Tattum MH; Panico S; Clare DK; Collinge J; Saibil HR; Wadsworth JD
    Open Biol; 2016 May; 6(5):. PubMed ID: 27249641
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Prion encephalopathies of animals and humans.
    Prusiner SB
    Dev Biol Stand; 1993; 80():31-44. PubMed ID: 8270114
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A single amino acid alteration in murine PrP dramatically alters TSE incubation time.
    Manson JC; Barron R; Jamieson E; Baybutt H; Tuzi N; McConnell I; Melton D; Hope J; Bostock C
    Arch Virol Suppl; 2000; (16):95-102. PubMed ID: 11214938
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A new model for sensitive detection of zoonotic prions by PrP transgenic Drosophila.
    Thackray AM; Andréoletti O; Spiropoulos J; Bujdoso R
    J Biol Chem; 2021 Aug; 297(2):100878. PubMed ID: 34270959
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Synthetic scrapie infectivity: interaction between recombinant PrP and scrapie brain-derived RNA.
    Simoneau S; Thomzig A; Ruchoux MM; Vignier N; Daus ML; Poleggi A; Lebon P; Freire S; Durand V; Graziano S; Galeno R; Cardone F; Comoy E; Pocchiari M; Beekes M; Deslys JP; Fournier JG
    Virulence; 2015; 6(2):132-44. PubMed ID: 25585171
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Pathology of SSLOW, a transmissible and fatal synthetic prion protein disorder, and comparison with naturally occurring classical transmissible spongiform encephalopathies.
    Jeffrey M; McGovern G; Makarava N; González L; Kim YS; Rohwer RG; Baskakov IV
    Neuropathol Appl Neurobiol; 2014 Apr; 40(3):296-310. PubMed ID: 23578208
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Mammalian prions generated from bacterially expressed prion protein in the absence of any mammalian cofactors.
    Kim JI; Cali I; Surewicz K; Kong Q; Raymond GJ; Atarashi R; Race B; Qing L; Gambetti P; Caughey B; Surewicz WK
    J Biol Chem; 2010 May; 285(19):14083-7. PubMed ID: 20304915
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Prion diseases: a riddle wrapped in a mystery inside an enigma.
    Liberski PP
    Folia Neuropathol; 2008; 46(2):93-116. PubMed ID: 18587704
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Bioassay of prion-infected blood plasma in PrP transgenic Drosophila.
    Thackray AM; Andreoletti O; Bujdoso R
    Biochem J; 2016 Dec; 473(23):4399-4412. PubMed ID: 27733649
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Self-Replication of Prion Protein Fragment 89-230 Amyloid Fibrils Accelerated by Prion Protein Fragment 107-143 Aggregates.
    Sneideris T; Ziaunys M; Chu BK; Chen RP; Smirnovas V
    Int J Mol Sci; 2020 Oct; 21(19):. PubMed ID: 33049945
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Protease-sensitive synthetic prions.
    Colby DW; Wain R; Baskakov IV; Legname G; Palmer CG; Nguyen HO; Lemus A; Cohen FE; DeArmond SJ; Prusiner SB
    PLoS Pathog; 2010 Jan; 6(1):e1000736. PubMed ID: 20107515
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.